scholarly journals Using the RIGHT statement to evaluate the reporting quality of clinical practice guidelines in traditional Chinese medicine

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0207580 ◽  
Author(s):  
Xia Yun ◽  
Chen Yaolong ◽  
Zeng Zhao ◽  
Zhou Qi ◽  
Wang Yangyang ◽  
...  
2020 ◽  
Author(s):  
Can Wang ◽  
Xufei Luo ◽  
Maichao Li ◽  
Lingling Cui ◽  
Xinde Li ◽  
...  

Abstract Objectives The Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist was used to assess the reporting quality of 2009–2019 Clinical Practice Guidelines (CPGs) regarding gout and hyperuricemia, aimed to improve the reporting quality of future guidelines.Methods We searched PubMed, the Chinese Biomedical Literature database, the Wan Fang Database, and the China National Knowledge Infrastructure from January 2009 to June 2019 for relevant guidelines. We also searched the websites of guideline development organizations (the Guidelines International Network, the National Institute for Health and Clinical Excellence, the American College of Rheumatology, and the European League Against Rheumatism) (EULAR). Furthermore, supplementary guidelines reported in included articles were systematically searched, as well as Medlive and Google Scholar. Results Seventeen guidelines were included, of which one was in Chinese and 16 were in English. The mean reporting rate of the 35 items specified was 14.9 (42.5%), only five CPGs (29.4%) had a reporting rate >50%. Of the 35 items, three were very frequently reported. The reporting proportion of the seven domains (Basic information, Background, Evidence, Recommendations, Review and quality assurance, Funding and declaration and management of interests, and Other information) were 64.7%, 36.8%, 50.6% 50.6%, 42.9%, 8.82%, 33.8%, and 31.4%, respectively.Conclusion The reporting quality of the present guidelines for gout and hyperuricemia is relatively poor. We suggest that the RIGHT reporting checklist should be used by CPG developers to ensure higher reporting quality of future guidelines.


2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Kefeng Liu ◽  
Yanfang Ma ◽  
Yongjie Yang ◽  
Jingli Lu ◽  
Jie Zhao ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Yongjie Yang ◽  
Yanfang Ma ◽  
Jingli Lu ◽  
Shuzhang Du ◽  
Jingmin Zhang ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Qiwen Zhang ◽  
Jingli Lu ◽  
Mengmeng Jia ◽  
Yanfang Ma ◽  
Mingyang Sun ◽  
...  

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Shuya Lu ◽  
Xufei Luo ◽  
Xiaojia Ni ◽  
Haoxuan Li ◽  
Miaomiao Meng ◽  
...  

Abstract Objectives To analyze the effectiveness and quality of stroke clinical practice guidelines (CPGs) published in recent years in order to guide future guideline developers to develop better guidelines. Participants No patient involved Method PubMed, China Biology Medicine (CBM), Wanfang, CNKI, and CPG-relevant websites were searched from January 2015 to December 2019 by two researchers independently. The RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was used to assess the reporting quality in terms of domains and items. Then, a subgroup analysis of the results was performed. Primary and secondary outcome measures RIGHT checklist reporting rate Results A total of 66 CPGs were included. Twice as many CPGs were published internationally as were published in China. More than half were updated. Most CPGs are published in journals, developed by societies or associations, and were evidence-based grading. The average reporting rate for all included CPGs was 47.6%. Basic information got the highest (71.7% ± 19.7%) reporting rate, while review and quality assurance got the lowest (22.0% ± 24.6%). Then, a cluster analysis between countries, publishing channels, and institutions was performed. There were no statistically significant differences in the reporting quality on the CPGs between publishing countries (China vs. international), publishing channels (journals vs. websites), and institutions (associations vs. non-associations). Conclusions Current stroke CPGs reports are of low quality. We recommend that guideline developers improve the quality of reporting of key information and improve the management of conflicts of interest. We recommend that guideline developers consider the RIGHT checklist as an important tool for guideline development. Trial registration 10.17605/OSF.IO/PBWUX.


Endocrine ◽  
2019 ◽  
Vol 65 (3) ◽  
pp. 531-541 ◽  
Author(s):  
Qianmei Wang ◽  
Yuting Duan ◽  
Jielin Liang ◽  
Ze Chen ◽  
Juexuan Chen ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Yongjie Yang ◽  
Jingli Lu ◽  
Yanfang Ma ◽  
Chen Xi ◽  
Jian Kang ◽  
...  

2021 ◽  
Author(s):  
Can Wang ◽  
Xufei Luo ◽  
Maichao Li ◽  
Lingling Cui ◽  
Xinde Li ◽  
...  

Abstract Background The Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist was used to assess the reporting quality of 2009–2019 Clinical Practice Guidelines (CPGs) regarding gout and hyperuricemia, aimed to improve the reporting quality of future guidelines.Methods We searched PubMed, the Chinese Biomedical Literature database, the Wan Fang Database, and the China National Knowledge Infrastructure from January 2009 to June 2019 for guidelines regarding gout and hyperuricemia. We also searched the websites of guideline development organizations (the Guidelines International Network, the National Institute for Health and Clinical Excellence, the American College of Rheumatology, and the European League Against Rheumatism) (EULAR). Furthermore, supplementary guidelines reported in included articles were systematically searched, as well as Medlive and Google Scholar.Results Seventeen guidelines were included, of which one was in Chinese and 16 were in English. The mean reporting rate of the 35 items specified was 14.9 (42.5%), only five CPGs (29.4%) had a reporting rate >50%. Of the 35 items, three were very frequently reported. The reporting proportion of the seven domains (Basic information, Background, Evidence, Recommendations, Review and quality assurance, Funding and declaration and management of interests, and Other information) were 64.7%, 36.8%, 50.6% 50.6%, 42.9%, 8.82%, 33.8%, and 31.4%, respectively.Conclusion The reporting quality of the present guidelines for gout and hyperuricemia is relatively poor. We suggest that the RIGHT reporting checklist should be used by CPG developers to ensure higher reporting quality of future guidelines.


Sign in / Sign up

Export Citation Format

Share Document